BioCorRx, Inc. Chief Financial Officer, Lourdes Felix and Brady Granier, Chief Operating Officer and Interim Chief Executive Officer, Discuss Recent News in a New Audio Interview at SmallCapVoice.com


AUSTIN, Texas, July 20, 2015 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and BioCorRx, Inc. (OTCQB:BICX) developer of the Start Fresh Program (R) used for the treatment of alcohol and opioid dependence, announced today that a new audio interview is now available. The interview can be heard at http://smallcapvoice.com/blog/7-16-15-smallcapvoice-interview-with-biocorrx-inc-bicx

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html or sign up for our FREE newsletter here http://www.smallcapvoice.com/newsletter.html.

Visit BioCorRx, Inc.'s investor relations website at www.BICXcorp.com to receive the most up to date company information.

Click here to view Recent National Television Media on the BioCorRx YouTube Channel

Click here for company Facebook page for more stories and media coverage

About BioCorRx, Inc.

BioCorRx, Inc. (R) (BICX) is an addiction treatment and rehabilitation company offering a unique approach to the treatment of substance abuse addiction. The Start Fresh Program(R), a medication-assisted treatment program, consists of two components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. Clinic reports show that the treatment program can be successful for individuals who complete the program. For more information on BICX, visit www.BioCorRx.com

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.



            

Tags


Contact Data